Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kura Oncology's enterprise value was $178.38M on Nov 11, 2026, against $516.38M a year earlier. Over the last 5 years it ranged from -$204.69M to $1.17B, with a median of $402.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $178.38M | -51.0% |
| 2025 | Dec 31, 2025 | $364.10M | +57.4% |
| 2024 | Dec 31, 2024 | $231.37M | -62.9% |
| 2023 | Dec 29, 2023 | $624.43M | +55.2% |
| 2022 | Dec 30, 2022 | $402.38M | +3.8% |
| 2021 | Dec 31, 2021 | $387.61M | -74.7% |
| 2020 | Dec 31, 2020 | $1.53B | +302.8% |
| 2019 | Dec 31, 2019 | $380.21M | -26.8% |
| 2018 | Dec 31, 2018 | $519.41M | +21.0% |
| 2017 | Dec 29, 2017 | $429.35M | +280.3% |
| 2016 | Dec 30, 2016 | $112.89M | +40.0% |
| 2015 | Dec 31, 2015 | $80.65M | – |
See a number that looks wrong?